EIF2A and Dystonia: Aberrant regulation of the eIF2α signaling pathway and therapeutic manipulation of eIF2α phosphorylation further support the notion that eIF2α signaling pathway dysregulation is one of the pathogenic mechanisms underlying DYT-TOR1A dystonia.